Futura Medical Share Discussion Threads

[lbo] 05/4/2023 15:35

Mike knows nothing has changed! The losses and ‘waffling’ keeps coming. Now this medical device is an even lower class device with less USP of even having any substantiated effct over even a standard arousal gel would in the same deficient tests and not even an enforceable patent! Its just an arousal gel made of alcohol, glycol and water!



Ingredients Water, ethanol (35%), propylene glycol, glycerin, carbomer






water-based warming gel Ingredients Stimulant Gel Aqua, Glycerin, Propylene Glycol, Alcohol Denat, Carbomer

[lbo] 05/4/2023 15:28

ROFLMAO

Yes indeed! Yes years pass by but still no sign ever of any meaningful revenues or even getting close to paying the Directors salaries!

‘Product revenue represents net invoice less estimated volume discounts, which are considered to be variable consideration and include significant estimates. Other variable considerations such as milestone payments and royalties are not recognised in full until it is highly probable that a significant reversal in the amount of cumulative revenue recognised will not occur. In management’s opinion, that will be when the Group’s customer confirms that the milestone has been met or that a royalty is due. Estimates associated with variable consideration are revisited at each reporting date or when they are resolved and revenue is adjusted accordingly’

So whats the revenue forecast for year end and what further losses this year and beyond! LOL

[keifer derrin] 05/4/2023 14:20

hxxps://www.futuramedical.com/investor-centre/videos-and-webcasts/webcasts/

interesting webcast of today's results and going forward. Well worth a listen

[lbo] 05/4/2023 10:39

But the ‘experts’ Petroc referenced openly said in the webinar with some men that ‘Their ED, if it is such, can actually be more a loss of confidence that they will be able to perform with their partner. Each of the Profs. felt that Eroxon was a safe alternative to stimulate the younger person's confidence’

So thats VERY RELEVANT and a very eloquent description of psychological ED or as the experts said ‘Their ED, if it such’ and the use of a Placebo gel to ‘stimulate’ confidence. So who is telling lies on what Eroxon actually is stimulating? The experts or the rampers!?

So its all based then on rampers marketing a ‘confidence’ trick based on men overpaying for an arousal gel as a ‘fake’ treatment. Or as the FTC said a placebo ‘ form of fraud’ and a ‘swindle’

Even an arousal gel made of alcohol, water, glycol and carbomer can replicate all the same massaging, cooling and placebo effects



Selling brass as gold harms consumers independent of any effect Since the placebo effect can be obtained from sugar pills, charging $200 for a device that is represented as a miracle cure but works no better than a dummy pill is a form of fraud.



A product that contemporary technology does not understand must establish that this magic, actually works. Proof is what separates an effect new to science from a swindle . . . . If a condition responds to treatment, then selling a placebo as if it had therapeutic effect directly injures the consumer



Confidence Placebos

When its time to perform’ on stage, in the boardroom, in the bedroom” confidence is the essential mental component to strong execution

So any male consumer who feels they were misled into overpaying for an arousal gel that contains alcohol, water, glycol and carbomer can now seek redress against the ‘legal manufacturer’



Unfair commercial practices

When you buy goods and services anywhere in the EU from a website, a local shop or a seller outside your home countrys EU law protects you against unfair commercial practices. When promoting, selling or supplying products, companies must give you enough accurate information to enable you to make an informed buying decision. Find out more about contract information. If they fail to provide this information, their actions may be considered unfair. You have the right to seek redress if you are treated unfairly.

Misleading and aggressive practices

You are protected against 2 main categories of unfair commercial practices: misleading practices, either through action (giving false information) or omission (leaving out important information) aggressive practices that aim to bully you into buying Certain commercial practices are prohibited in all circumstances. Some of the most common are listed below:

Whenever a product is advertised as therapeutic, curing allergies, reversing hair loss, helping you lose weight, etc. you have the right to know if such claims have been scientifically confirmed.

In many cases, claims like these are not medically backed up and are simply TOO GOOD TO BE TRUE

[petroc] 05/4/2023 10:29

Everything LiarBO says is entirely irrelevant and usually a lie.

[lbo] 05/4/2023 10:19

But mike has already told us everything from Futura is 'waffling smoke screen' 'which have turned out to end in exactly nothing'!mikethebike4 - 11 Apr 2018 - 14:35:10 - 4072 of 11141Having had similar waffling, 'smoke-screen' answers from Mr Barder over the years which have turned out to end in exactly nothing I am loathe to give any credence to virtually everything he saysmikethebike4 - 11 Apr 2018 - 15:58:28 - 4091 of 11141Company is massively over valued if you go by 'concrete' results !mikethebike4 - 11 Apr 2018 - 15:14:56 - 4082 of 11141I only try and bring some sort of balance into the equation to help the gullible not get carried away with fanciful future projections.I would like nothing better than to be proved wrong about Mr Barder (our CEO since 2001) and to sale away into the sunset grasping 5 times as many £s in my fist as I paid for the sharesUnfortunately for people like J7J, Mr Barder has been through this advisors process before - with CSD500 - and look where we've got in 17 years - sales of the product did not even equal the money we paid him to be our CEO for 2017 !mikethebike4 - 06 Dec 2017 - 10:32:27 - 3468 of 10591"A couple of decent deals and will be back off to the races."Do you have any idea of how long shareholders have been using these wordsmikethebike4 - 23 Mar 2017 - 09:52:33 - 2560 of 10591As someone who has been invested for many years and who attended an AGM years ago and complained to Barder about the very slow progress, I am very frustrated.All the time the Board are drawing good salaries off the backs of shareholders money they have very little incentive to get off their backsides and get 'selling' - thats what running a company is all about at the end of the day!mikethebike4 - 24 Feb 2020 - 09:11:58 - 7290 of 9713why should it be any different this time when you've still got the same useless lot running the showmikethebike4 - 07 Jan 2019 - 11:22:52 - 4692 of 9641I repeat I very much hope you are right - no one would be happier than me if you are - however I stupidly (in hindsight) bought in when everything looked really rosy - we were told there were loads of 'distributors' all 'champing at the bit to get selling a wonderful industry disruptive product (which it still is incidentally) once the 2 year shelf-life problem was fixed. This was despite the fact that the Holland/Belgium distributor was quite happy and successful selling them with the original 18 months shelf-lifeAnd where are we now years later - one tiny distributor from which Futura receives a total sales income only just about covering Mr Barders employment remunerationI just hope this MED/TPR situation is not just a repeat of CSD. As to why I don't just sell up, well my shareholding is worth such a tiny proportion of what I paid for it I might just as well hang on in the hope that new shareholders getting in now are luckier than I was and I can get some of my money back - I think what we need is Mr Barders retirement - that should give the share price a kick

[lbo] 05/4/2023 10:14

Ah yes the old ‘manufacturing orders’! LOL


Not much real revenue ever materialised for shareholders from the CSD500 ‘manufacturing orders’!!!


jamesd888 - 14 Jun 2017 - 09:14:23 - 2869 of 17743

AGM Statement today

"On CSD500, our novel erectogenic condom, we are currently assisting all our EU licensing partners wherever required with their launch plans in a number of countries. In addition, we have in production two manufacturing orders from our licensing partner for the Middle East and North Africa, following its launch of CSD500 in Saudi Arabia earlier this year.

"We continue in discussions on the out-licensing of our two pain relief products, TIB200 and TPR100, with potential licensing partners. We look forward to providing an update on these discussions, and on other corporate developments, in due course.

"Futura continues to benefit from a strong financial position and we look forward to the year ahead with confidence."

[ajmace] 05/4/2023 07:34

Looking good for a blue day

[broomrigg] 05/4/2023 07:11

RNS......"Current cash runway extends beyond initial Eroxon(R) launches expected over the next year and expected US regulatory approval in 2023"Brilliant :-)

[lbo] 04/4/2023 13:17

But the ‘experts’ Petroc referenced openly said in the webinar with some men that ‘Their ED, if it is such, can actually be more a loss of confidence that they will be able to perform with their partner. Each of the Profs. felt that Eroxon was a safe alternative to stimulate the younger person's confidence’

So thats very relevant and a very eloquent description of psychological ED or as the experts said ‘Their ED, if it such’ and the use of a Placebo gel to ‘stimulate’ confidence’. So who is telling lies on what Eroxon actually is stimulating? The experts or the rampers!?

So its all based then on rampers marketing a ‘confidence’ trick based on men overpaying for an arousal gel as a ‘fake’ treatment. Or as the FTC said a placebo ‘form of fraud’ and a ‘swindle’.



Selling brass as gold harms consumers independent of any effect Since the placebo effect can be obtained from sugar pills, charging $200 for a device that is represented as a miracle cure but works no better than a dummy pill is a form of fraud.



A product that contemporary technology does not understand must establish that this magic, actually works. Proof is what separates an effect new to science from a swindle . . . . If a condition responds to treatment, then selling a placebo as if it had therapeutic effect directly injures the consumer



Confidence Placebos

When it’s time to perform — on stage, in the boardroom, in the bedroom — confidence is the essential mental component to strong execution

So any male consumer who feels they were misled into overpaying for an arousal gel that contains alcohol, water, glycol and carbomer can now seek redress against the ‘legal manufacturer’.



Unfair commercial practices

When you buy goods and services anywhere in the EU from a website, a local shop or a seller outside your home countrys EU law protects you against unfair commercial practices. When promoting, selling or supplying products, companies must give you enough accurate information to enable you to make an informed buying decision. Find out more about contract information. If they fail to provide this information, their actions may be considered unfair. You have the right to seek redress if you are treated unfairly.

Misleading and aggressive practices

You are protected against 2 main categories of unfair commercial practices: misleading practices, either through action (giving false information) or omission (leaving out important information) aggressive practices that aim to bully you into buying Certain commercial practices are prohibited in all circumstances. Some of the most common are listed below:

Whenever a product is advertised as therapeutic, curing allergies, reversing hair loss, helping you lose weight, etc. you have the right to know if such claims have been scientifically confirmed.

In many cases, claims like these are not medically backed up and are simply TOO GOOD TO BE TRUE

[petroc] 04/4/2023 12:50

Everything LiarBO says is entirely irrelevant and usually a lie.

[lbo] 04/4/2023 12:05

Yes indeed all very sad! Still their own words at it and coming back to haunt them! LOL

They are now so desperate to get out themselves before yet another fundraising. Then when that money runs out yet again and the revenues yet again fail to materialise from a medical device placebo gel with no enforceable patent to justify that in their own words the ‘company is massively overvalued if you go by concrete results’

JoeStalin - 22 Jan 2018 - 11:16:41 - 3640 of 17304

Only a clown thinks selling a few packs at all makes for a business.

JoeStalin - 30 Sep 2019 - 10:07:37 - 5937 of 10774
FUTURA a winner for 2015 - says it all!


JoeStalin - 18 Jul 2018 - 09:00:46 - 4354 of 10775
'jam tomorrow' is a very easy promise to make.


JoeStalin - 22 Jun 2018 - 14:12:24 - 4288 of 10775
What's another year after all?
At FUM, time is measured in decades.


JoeStalin - 25 Apr 2018 - 16:07:34 - 4147 of 10775
There seems to be an unlimited number of ways of saying "Jam tomorrow".


JoeStalin - 21 Mar 2018 - 13:50:44 - 3985 of 10775
A lifestyle company, but not for the shareholders

mikethebike4 - 11 Apr 2018 - 14:35:10 - 4072 of 11141

Having had similar waffling, 'smoke-screen' answers from Mr Barder over the years which have turned out to end in exactly nothing I am loathe to give any credence to virtually everything he says

mikethebike4 - 11 Apr 2018 - 15:58:28 - 4091 of 11141

Company is massively over valued if you go by 'concrete' results !

mikethebike4 - 11 Apr 2018 - 15:14:56 - 4082 of 11141

I only try and bring some sort of balance into the equation to help the gullible not get carried away with fanciful future projections.
I would like nothing better than to be proved wrong about Mr Barder (our CEO since 2001) and to sale away into the sunset grasping 5 times as many £s in my fist as I paid for the shares
Unfortunately for people like J7J, Mr Barder has been through this advisors process before - with CSD500 - and look where we've got in 17 years - sales of the product did not even equal the money we paid him to be our CEO for 2017 !

mikethebike4 - 06 Dec 2017 - 10:32:27 - 3468 of 10591

"A couple of decent deals and will be back off to the races."
Do you have any idea of how long shareholders have been using these words

mikethebike4 - 23 Mar 2017 - 09:52:33 - 2560 of 10591

As someone who has been invested for many years and who attended an AGM years ago and complained to Barder about the very slow progress, I am very frustrated.
All the time the Board are drawing good salaries off the backs of shareholders money they have very little incentive to get off their backsides and get 'selling' - thats what running a company is all about at the end of the day!

mikethebike4 - 24 Feb 2020 - 09:11:58 - 7290 of 9713

why should it be any different this time when you've still got the same useless lot running the show

mikethebike4 - 07 Jan 2019 - 11:22:52 - 4692 of 9641

I repeat I very much hope you are right - no one would be happier than me if you are - however I stupidly (in hindsight) bought in when everything looked really rosy - we were told there were loads of 'distributors' all 'champing at the bit to get selling a wonderful industry disruptive product (which it still is incidentally) once the 2 year shelf-life problem was fixed. This was despite the fact that the Holland/Belgium distributor was quite happy and successful selling them with the original 18 months shelf-life
And where are we now years later - one tiny distributor from which Futura receives a total sales income only just about covering Mr Barders employment remuneration
I just hope this MED/TPR situation is not just a repeat of CSD. As to why I don't just sell up, well my shareholding is worth such a tiny proportion of what I paid for it I might just as well hang on in the hope that new shareholders getting in now are luckier than I was and I can get some of my money back - I think what we need is Mr Barders retirement - that should give the share price a kick

[joestalin] 04/4/2023 11:54

all very sad...

[lbo] 04/4/2023 10:57

Yes tackems and all the brokers are still forecasting more losses for this year!

And still zero signs of any of the ‘Futura will receive an initial upfront payment’ in the last results after all the supposedly amazing agreements with Labatec, Menarini and Cooper etc!

And all the time the clock ticks down on the patents. The original EU patent on Med2005 expires in 2025! And the Cooper deal in the EU was for only 5 years and over a year of that has already gone! The brokers also admitted in the research notes they are assuming the original Med2002/2005 patents which we know expire in 2025 in EU and USA in 2028. Will provide some protection to Med3000 until then. Thats a big assumption! As the original patent was an umbrella patent covering Dermasys with GTN. But now Med3000/Eroxon is just Dermasys on its own and now just a medical device that requires manual stimulation and delivering only a cooling sensation via ‘evaporative cooling’




‘Therefore, from June 2022 it had roughly 13 months of cash runway’

‘it's fair to say the end of the cash runway is in sightâ

[lbo] 04/4/2023 10:53

Yes you are still at it mike! I am also ‘loathe to give credence to virtually everything’ you and your multi-ID bots keep ramping out on repeat!

And a placebo medical device gels main competitor is not a proven more effective then placebo drug like Viagra. But rather its just an arousal gel made from the same alcohol, water, glycol and carbomer ingredients as in Med3000!

Arousal gels too can replicate all the same massaging, cooling and placebo effects in the same deficient tests





water-based warming gel Ingredients Stimulant Gel Aqua, Glycerin, Propylene Glycol, Alcohol Denat, Carbomer


mikethebike4 - 11 Apr 2018 - 14:35:10 - 4072 of 11141

Having had similar waffling, 'smoke-screen' answers from Mr Barder over the years which have turned out to end in exactly nothing I am loathe to give any credence to virtually everything he says

mikethebike4 - 11 Apr 2018 - 15:58:28 - 4091 of 11141

Company is massively over valued if you go by 'concrete' results !

mikethebike4 - 11 Apr 2018 - 15:14:56 - 4082 of 11141

I only try and bring some sort of balance into the equation to help the gullible not get carried away with fanciful future projections.
I would like nothing better than to be proved wrong about Mr Barder (our CEO since 2001) and to sale away into the sunset grasping 5 times as many £s in my fist as I paid for the shares
Unfortunately for people like J7J, Mr Barder has been through this advisors process before - with CSD500 - and look where we've got in 17 years - sales of the product did not even equal the money we paid him to be our CEO for 2017 !

mikethebike4 - 06 Dec 2017 - 10:32:27 - 3468 of 10591

"A couple of decent deals and will be back off to the races."
Do you have any idea of how long shareholders have been using these words

mikethebike4 - 23 Mar 2017 - 09:52:33 - 2560 of 10591

As someone who has been invested for many years and who attended an AGM years ago and complained to Barder about the very slow progress, I am very frustrated.
All the time the Board are drawing good salaries off the backs of shareholders money they have very little incentive to get off their backsides and get 'selling' - thats what running a company is all about at the end of the day!

mikethebike4 - 24 Feb 2020 - 09:11:58 - 7290 of 9713

why should it be any different this time when you've still got the same useless lot running the show

mikethebike4 - 07 Jan 2019 - 11:22:52 - 4692 of 9641

I repeat I very much hope you are right - no one would be happier than me if you are - however I stupidly (in hindsight) bought in when everything looked really rosy - we were told there were loads of 'distributors' all 'champing at the bit to get selling a wonderful industry disruptive product (which it still is incidentally) once the 2 year shelf-life problem was fixed. This was despite the fact that the Holland/Belgium distributor was quite happy and successful selling them with the original 18 months shelf-life
And where are we now years later - one tiny distributor from which Futura receives a total sales income only just about covering Mr Barders employment remuneration
I just hope this MED/TPR situation is not just a repeat of CSD. As to why I don't just sell up, well my shareholding is worth such a tiny proportion of what I paid for it I might just as well hang on in the hope that new shareholders getting in now are luckier than I was and I can get some of my money back - I think what we need is Mr Barders retirement - that should give the share price a kick

[tackems] 04/4/2023 10:39

Results tomorrow...

[lbo] 04/4/2023 10:09

As the ‘experts’ openly stated in the webinar with some men that ‘Their ED, if it is such, can actually be more a loss of confidence that they will be able to perform with their partner. Each of the Profs. felt that Eroxon was a safe alternative to stimulate the younger person's confidence’

Thats a very eloquent description of psychological ED or as the experts said ‘Their ED, if it such’ and the use of a Placebo gel to ‘stimulate’ confidence’

So its all based then on rampers marketing a ‘confidence’ trick based on men overpaying for an arousal gel as a ‘fake’ treatment. Or as the FTC said a placebo ‘form of fraud’ and a ‘swindle’.



Selling brass as gold harms consumers independent of any effect Since the placebo effect can be obtained from sugar pills, charging $200 for a device that is represented as a miracle cure but works no better than a dummy pill is a form of fraud.



A product that contemporary technology does not understand must establish that this magic, actually works. Proof is what separates an effect new to science from a swindle . . . . If a condition responds to treatment, then selling a placebo as if it had therapeutic effect directly injures the consumer



Confidence Placebos

When it’s time to perform — on stage, in the boardroom, in the bedroom — confidence is the essential mental component to strong execution

So any male consumer who feels they were misled into overpaying for an arousal gel that contains alcohol, water, glycol and carbomer can now seek redress against the ‘legal manufacturer’.



Unfair commercial practices

When you buy goods and services anywhere in the EU from a website, a local shop or a seller outside your home countrys EU law protects you against unfair commercial practices. When promoting, selling or supplying products, companies must give you enough accurate information to enable you to make an informed buying decision. Find out more about contract information. If they fail to provide this information, their actions may be considered unfair. You have the right to seek redress if you are treated unfairly.

Misleading and aggressive practices

You are protected against 2 main categories of unfair commercial practices: misleading practices, either through action (giving false information) or omission (leaving out important information) aggressive practices that aim to bully you into buying Certain commercial practices are prohibited in all circumstances. Some of the most common are listed below:

Whenever a product is advertised as therapeutic, curing allergies, reversing hair loss, helping you lose weight, etc. you have the right to know if such claims have been scientifically confirmed.

In many cases, claims like these are not medically backed up and are simply TOO GOOD TO BE TRUE

[petroc] 04/4/2023 09:53

Everything LiarBO says is entirely irrelevant and usually a lie.